Novo Nordisk has more than enough of its Wegovy weight-loss pills to support an aggressive product launch, CEO Mike Doustdar ...

The cash price for popular weight-loss medication Wegovy is dropping by 30% in U.S. on Monday, according to Novo Nordisk.

Plus, semaglutide’s patent expiry across major emerging markets, including India, Brazil and China, is expected to open the ...

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long ...

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...

Coffee beans contain powerful antioxidants. Here's what the research says about coffee's impact on heart health, brain health ...

New State Department guidance encourages embassies and consulates to deny visas to people with obesity or other health issues ...

The Trump administration initially walked back a Biden-era attempt to broaden Medicare coverage of weight loss drugs, which Kennedy has been critical of. Senior administration officials called ...

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce ...

Share on Pinterest The U.S. obesity rate is declining as more people turn to GLP-1 drugs for weight loss. Bloomberg/Getty Images A new Gallup poll indicates that the rate of obesity among U.S. adults ...